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ABSTRACT: Transfecting nucleic acids into various cells is a key
procedure in biological research also envisioned for therapeutic
applications. In our effort to obtain simple reagents that would be
readily accessible from commercial building blocks, we recently
reported peptide dendrimers as single component siRNA trans-
fection reagents accessible in pure form by solid-phase peptide
synthesis. Here, we extend our studies of these dendrimers by
identifying analogs bearing a coumarin or BODIPY fluorescent
label in their core and displaying comparable siRNA transfection
efficiencies, pH dependent aggregation, siRNA binding, and
secondary structures. Fluorescence resonance energy transfer
(FRET) studies show that the dendrimers are tightly associated
with siRNA within the formed nanoparticles at pH 7.4 but are released into solution at pH 5.0 and can participate in endosome
escape by destabilizing the membrane at this pH value. Colocalization studies furthermore suggest that peptide dendrimers and
siRNA remain tightly associated throughout the transfection process.
■ INTRODUCTION
Transfecting cells with nucleic acids to modulate protein
expression is an essential procedure in biological research also
envisioned for therapeutic applications.1−5 A broad variety of
hydrophobic polycations have been developed as transfection
reagents to overcome limitations of viral vectors in terms of
safety and genetic variability,6−9 spanning from lipids10−14 to
polymers,15−21 dendrimers,22−27 and nanoparticles;28−32 how-
ever, many of these reagents are polymeric mixtures or
complex reagents requiring nonstandard syntheses, which
limits transferability of results.
In our effort to obtain simple reagents that would be readily
accessible from commercial building blocks, we have
developed transfection reagents based on lysine branched
peptide dendrimers accessible in pure form by solid-phase
peptide synthesis.33−35 We initially discovered peptide
dendrimers with specific amino acid sequences in their
branches enabling either DNA or siRNA transfection when
used in combination with lipofectin.36−38 Introducing hydro-
phobic groups at the dendrimer core, in particular, fatty acids
similarly to the approach taken by others to optimize cell
penetrating peptides for membrane interaction and self-
assembly,39−41 later enabled us to obtain dendrimers acting
as single component siRNA transfection reagents. We obtained
the best siRNA transfection activities with D-enantiomeric
dendrimers DMH13 with a pair of palmitic acids and DMH18
with a leucine tetrapeptide as hydrophobic cores (Figure 1a).42
Mechanistic studies showed that DMH13 and DMH18
aggregate at neutral pH via intermolecular β-sheets to form
nanoparticles in combination with siRNA, which enter cells by
endocytosis. Endosome acidification then induces the proto-
nation of the dendrimer amino termini, which triggers a
conformational rearrangement of the peptide dendrimer to an
α-helical conformation and a rearrangement of the nano-
particle with partial release of free dendrimer with membrane
disruptive activity, inducing endosome escape and delivery of
the siRNA cargo into the cytosol (Figure 1b).42
Despite our detailed previous investigations, important
aspects of the proposed transfection mechanism remained
speculative because DMH13 and DMH18 could not be
tracked directly during siRNA complexation and transfection.
We therefore set out to identify fluorescence labeled analogs to
perform FRET based proximity studies and track the
localization of the dendrimers during transfection. Indeed,
various labeling studies reported on siRNA43−49 or transfection
reagents39,50−52 have been shown to provide useful insight into
the transfection process. Considering that a variety of
dendrimer core modifications were compatible with siRNA
transfection if the dendrimer branches were kept constant, we
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designed our fluorescently labeled dendrimers by modifying
the dendrimer core with hydrophobic fluorescent labels.
Herein we detail the identification of siRNA transfection
dendrimers bearing a coumarin (D1C/D3C) or BODIPY
(D1B/D3B) label in their core and show that these labeled
dendrimers display siRNA transfection and structure−property
relationships that are comparable to their nonlabeled parent
dendrimers DMH13 and DMH18. We then use these
dendrimers to deepen our understanding of the transfection
process by directly measuring the interaction between
dendrimer and siRNA using fluorescence resonance energy
transfer (FRET), by measuring their vesicle leakage activity
under the low pH conditions of the endosome, and by
monitoring the localization of both siRNA and transfection
dendrimer within the cells during the transfection process by
confocal microscopy.
■ RESULTS AND DISCUSSION
Identification of Fluorescent siRNA Transfection
Dendrimers. We initially focused on 7-diethylamino-4-
methyl-3(4-acetamidophenyl)-coumarin (λex = 390 nm, λem =
470 nm) as a fluorescent label, thereafter referred to as
“coumarin”, because it can be recorded using standard
fluorescence microscopes without interference with the Cy3
fluorescent label for siRNA (λex = 530 nm, λem = 574 nm) and
the Quant-it microRNA dye used to measure siRNA binding.53
To obtain fluorescent versions of our transfection dendrimers,
we modified their sequence by inserting a cysteine residue at
the dendrimer core and alkylating it with 7-diethylamino-4-
methyl-3(4-iodacetamidophenyl)-coumarin,54 simultaneously
adjusting the composition of the core to obtain an optimal
hydrophobicity for efficient siRNA transfection.
Figure 1. siRNA transfection mediated by peptide dendrimers as single component reagents. (a) Schematic structure of transfection dendrimers
from previous study (DMH13/DMH18) and their fluorescent analogs discussed here (D1C/D1B, D3C/D3B). (b) Mechanism of peptide
dendrimer mediated siRNA transfection. Black arrows indicate new insights reported here using fluorescence labeled dendrimers.
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For dendrimers MH13/DMH13 bearing two palmitoyl
groups at their core, we inserted the cysteine residue before the
first branching point as the fluorophore attachment point,
while reducing the length of the pair of fatty acyl chains from
C16 to C12 to adjust core hydrophobicity, providing dendrimers
1C/D1C. For MH18, which contains a tetra-leucine sequence
as hydrophobic core, we inserted a cysteine residue at the first
position of the core and gradually shortened the tetra-leucine
sequence to form fluorescent versions 2C, 3C, 4C, and 5C. We
also prepared fluorescent versions of two MH18 analogs with
previously identified inactivating modifications in the den-
drimer branches as negative controls, namely, 6C (L → K
exchange in G1, reduces siRNA binding and abolishes
transfection) and 7C (K → L exchange in G2, induces
Scheme 1. Synthesis and Structure of D1Ca
aFor intermediate D1, single letter codes indicate D-amino acids, connections indicate peptide bonds, and wobble connections indicate amide to
the ε-amino group of lysine, C12 = lauroyl amide on lysine side chain. D1C is shown with the protonation state at pH 7.4. Conditions: (a) (i) 5
equiv/coupling-site Fmoc-amino acid, 5 equiv/coupling site Oxyma, 5 equiv/coupling site DIC in DMF, 1−5 min, 75−90 °C; (ii) Piperidine/DMF
(1:4, v/v), 2 min, 75−90 °C. (iii) P(PPh3)4 (0.25 equiv/alloc group), (CH3)2NH·BH3 (25 equiv/alloc group), 2 × 60 min, 25 °C; (iv) Palmitic
acid (5 equiv/coupling site), DIC (5 equiv/coupling site), Oxyma (5 equiv/coupling site) in NMP, 60 min−overnight; (v) CF3CO2H (94%), i-
Pr3SiH (2.5%), DODT (2.5%), H2O (1%), 5 h, 25 °C. (b) Reversed phase C18 preparative HPLC, gradient 0−70% CH3CN/H2O/0.1% TFA over
45 min. (c) 1 equiv D1, 1.1 equiv (7)-diethylamino-3-[4-(iodoacetamido)phenyl]-4-methylcoumarin, in H2O/ACN (1:1, v/v), 120 min, 25 °C.
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stronger siRNA binding preventing its release and knock-down
activity). We synthesized all dendrimers by automated solid-
phase peptide synthesis (SPPS) followed by preparative RP-
HPLC purification. We performed cysteine alkylation in
aqueous acetonitrile under slightly alkaline conditions and
purified the final product by preparative RP-HPLC (Scheme 1,
Scheme S1 and Table 1).
For transfection studies, we used a 21 nucleotide double-
stranded siRNA for knocking down glyceraldehyde phosphate
dehydrogenase (GADPH).55,56 We measured siRNA binding
using the fluorogenic intercalating dye Quant-it microRNA53
and knock-down efficiency by measuring GADPH activity in
HeLa cells, a standard cell line for transfection studies, using a
chromogenic reporter system57−59 after 4 h transfection with
dendrimer/siRNA complexes at 100 nM siRNA and N/P = 10,
and 48 h incubation, in comparison with the same experiment
using a scrambled sequence mock siRNA (siNC).
Fluorescent dendrimers 1C/D1C bound and transfected
siRNA to a comparable extent to their parent dendrimers
MH13/DMH13 and the reference reagent lipofectamine 2000
(L2000). The D-enantiomeric D1C showed a slightly stronger
activity than 1C, which reproduced the previously observed
stronger activity of DMH13 over MH13. In the case of the
fluorescent version of MH18, dendrimers 2C, 3C, 4C, and 5C
bound siRNA as tightly as the parent dendrimer as indicated
by only very low residual Quant-it microRNA fluorescence.
However, only 3C, with three leucine residues in its core,
matched MH18 in terms of transfection efficiency. We
therefore also prepared D-enantiomeric dendrimer D3C,
which turned out slightly more active than the L-enantiomer
3C in terms of knock-down, reproducing the difference
between the previously reported MH18 and DMH18. Finally,
fluorescent dendrimers 6C and 7C designed as negative
controls displayed the expected siRNA binding and absence of
GADPH knock-down.
Table 1. Synthesis, siRNA Binding, and Transfection with Fluorescence Labeled Peptide Dendrimers
compound sequencea posb hydc yieldd mg (%) MSe calc./obs. free siRNAf [%] GAPDH activityg [%]
L2000h n.a. n.a. n.a. n.a. n.a. 32.2 ± 2 34 ± 4
MH13h (KL)8(KKL)4(KLL)2KK(C16)K(C16) 12 20 26.8 (4) 4992.83/4992.82 4.8 ± 0.7 32 ± 5
1 (KL)8(KKL)4(KLL)2KCK(C12)K(C12) 12 18 34.2 (5) 4983.71/4983.71
1C (KL)8(KKL)4(KLL)2KC(Cmr)K(C12)K(C12) 12 18 3.6 (42) 5345.87/5345.88 1.7 ± 0.2 34 ± 13
DMH13h (kl)8(kkl)4(kll)2kk(C16)k(C16) 12 20 128.4 (7) 4992.83/4992.84 3.9 ± 0.5 31 ± 2
D1 (kl)8(kkl)4(kll)2kck(C12)k(C12) 12 18 62 (10) 4983.71/4983.71
D1C (kl)8(kkl)4(kll)2kc(Cmr)k(C12)k(C12) 12 18 3.4 (33) 5345.87/5345.89 1.6 ± 0.1 24 ± 5
MH18h (KL)8(KKL)4(KLL)2KLLLL 12 20 52.7 (8) 4712.51/4712.52 4.8 ± 0.4 28 ± 9
2 (KL)8(KKL)4(KLL)2KLLLLC 12 20 27 (4) 4815.52/4815.55 2.7 ± 0.3 69 ± 18
2C (KL)8(KKL)4(KLL)2KLLLLC(Cmr) 12 20 1.7 (32) 5177.68/5177.69 1.6 ± 0.2 75 ± 20
3 (KL)8(KKL)4(KLL)2KLLLC 12 19 33.4 (7) 4702.44/4702.45 3.7 ± 0.3 55 ± 2
3C (KL)8(KKL)4(KLL)2KLLLC(Cmr) 12 19 2.1 (42) 5064.60/5064.61 2.9 ± 0.1 33 ± 3
4 (KL)8(KKL)4(KLL)2KLLC 12 18 57.2 (8) 4589.35/4589.36
4C (KL)8(KKL)4(KLL)2KLLC(Cmr) 12 18 3.6 (35) 4951.52/4951.53 3.8 ± 0.5 52 ± 0
5 (KL)8(KKL)4(KLL)2KC 12 16 7 (2) 4363.19/4363.19
5C (KL)8(KKL)4(KLL)2KC(Cmr) 12 16 2.8 (26) 4725.35/4725.36 4.1 ± 0.1 89 ± 5
DMH18h (kl)8(kkl)4(kll)2kllll 12 20 73.6 (11) 4712.51/4712.52 4.6 ± 0.7 28 ± 9
D3 (kl)8(kkl)4(kll)2klllc 12 19 129.5 (21) 4702.44/4702.48 3.2 ± 0.1 33 ± 1
D3C (kl)8(kkl)4(kll)2klllc(Cmr) 12 19 6.6 (32) 5064.60/5064.62 2.7 ± 0.3 24 ± 2
MH46h (KL)8(KKL)4(KKL)2KLLLL 14 18 8.5 (2) 4742.53/4742.55 7.7 ± 0.9 90 ± 9
6 (KL)8(KKL)4(KKL)2KLLLC 14 17 47.2 (10) 4732.46/4732.46
6C (KL)8(KKL)4(KKL)2KLLLC(Cmr) 14 17 2.8 (31) 5094.62/5064.64 6.9 ± 0.6 68 ± 4
MH47h (KL)8(K LL)4(KLL)2KLLLL 8 24 10.1 (2) 4652.47/4652.49 3 ± 0.1 77 ± 14
7 (KL)8(KLL)4(KLL)2KLLLC 8 23 65.1 (14) 4642.39/4642.40
7C (KL)8(KLL)4(KLL)2KLLLC(Cmr) 8 23 3.9 (37) 5004.56/5004.58 1.3 ± 0.1 71 ± 5
1B (KL)8(KKL)4(KLL)2KC(Bdp)K(C12)K(C12) 12 18 2.9 (35) 5244.85/5243.83 n.a. 39 ± 7
D1B (kl)8(kkl)4(kll)2kc(Bdp)k(C12)k(C12) 12 18 2.4 (29) 5244.85/5243.83 n.a. 37 ± 0
3B (KL)8(KKL)4(KLL)2KLLLC(Bdp) 12 19 3.1 (37) 4963.57/4962.55 n.a. 30 ± 3
D3B (kl)8(kkl)4(kll)2klllc(Bdp) 12 19 2.6 (31) 4963.57/4962.56 n.a. 34 ± 2
6B (KL)8(KKL)4(KKL)2KLLLC(Bdp) 14 17 4.0 (47) 4903.53/4902.55 n.a. 95 ± 8
7B (KL)8(KLL)4(KLL)2KLLLC(Bdp) 8 23 4.9 (63) 4993.60/4992.60 n.a. 80 ± 5
aOne-letter-code amino acids, K is the branching lysine residue, C-termini are carboxamide CONH2, all N-termini are free. Three-letter-code short
names are used for fluorophores coupled to peptide dendrimers: 7-Diethylamino-3-[4-(iodoacetamido)phenyl]-4-methylcoumarin (Cmr), 8-
Bromomethyl-4,4-Difluoro-1,3,5,7-Tetramethyl-4-Bora-3a-4a-Diaza-s-Indacene (Bdp). bPos = number of positive charges estimated at neutral pH,
+1 for lysine, N-termini as NH2 at neutral pH.
cHyd = number of hydrophobic side chains. Leucine = 1, Lys(C16) = 2.
dIsolated yields as
trifluoroacetate salt after preparative HPLC purification. eESI-MS, see also the Supporting Information. fFluorescence from intercalation in siRNA
(20 nM) in complex with peptide dendrimer (N/P 10, 420 nM, 3 μg/mL) or L2000 (2:1, 532 ng/mL) by Quant-it microRNA performed in
triplicate and normalized to the value of siRNA alone. gGAPDH activity in HeLa cells after 4 h transfection by siRNA (100 nM) and peptide
dendrimers (N/P 10, 2.1 μM, 15 μg/mL) or L2000 (2:1, 2.66 μg/mL) followed by 48 h incubation in DMEM supplemented with 10% FCS and
normalized to siNC (negative control). hData and analysis present in previous report.42 Experiments were carried out in triplicate in three
independent experiments. Bar graph representation and parallel transfection with siNC are shown in Figure S1. n.a. = not applicable. Missing
entries were not determined.
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In view of performing fluorescence resonance energy transfer
(FRET) studies between Cy3-labeled siRNA and our
dendrimers, we prepared analogs of the 1C/D1C, 3C/D3C,
6C, and 7C dendrimers carrying a BODIPY (1B/D1B, 3B/
D3B as 6B and 7B, Bdp, λex = 493 nm, λem = 520 nm). These
BODIPY labeled dendrimers were obtained by alkylation of
cysteine intermediates 10, D10, 4, D4, 6, and 7 with 8-
bromomethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a-4a-
diaza-s-Indacene.60 While siRNA binding could not be assessed
in this series due to interference of BODIPY with the Quant-it
microRNA assay, these fluorescent dendrimers displayed the
expected siRNA transfection efficiencies, although there were
no significant differences between L- and D-enantiomers in this
series. On the other hand, labeling with dansyl, bimane,
methoxyphenyloxazolylpyridinium, and aminofluorescein abol-
ished transfection with MH18 analogs and only partially
preserved it for analogs of its enantiomer DMH18 (Table S1).
Additional fluorescent labels (Pyrene, Cyanine 7, and Cyanine
7.5) and dendrimers were also investigated but mostly showed
only modest transfection activities (Table S2).
Taken together, these experiments showed that fluorescent
versions of our transfection dendrimers labeled with coumarin
and BODIPY largely preserved siRNA binding and transfection
abilities, including their negative controls. Similar properties
were observed in CHO and HEK-293 cells, another two cell
lines often used for transfection studies (Figure S2). In all
cases, there was no significant difference in GADPH activity
between cells treated with dendrimer complexes of scrambled
siRNA and untreated cells, suggesting that our fluorescent
dendrimers did not affect cell viability (Figure S1), which was
verified further by a dedicated cell viability assay in the case of
the coumarin labeled analogs (Figure S3).
For further investigations, we selected 1C/D1C and 1B/
D1B as fluorescent versions of transfection dendrimers
MH13/DMH13 with a lipidated core and 3C/D3C and 3B/
D3B as fluorescent versions of transfection dendrimers
MH18/DMH18 with an oligoleucine core. We also included
the above-mentioned negative controls 6C/6B and 7C/7B.
pH Dependent Aggregation, Secondary Structure
Content, and siRNA Binding. Our fluorescent dendrimers
exhibited pH-dependent aggregation, as revealed by using the
Nile Red assay (Figure 2a/b and Figure S4).61 For transfection
dendrimers 1C/D1C and 1B/D1B with a lipidated core (red
curves), we observed a transition from high aggregation above
pH 6, corresponding to the extracellular medium, to a low
aggregation below pH 5.5 corresponding to the acidified
endosome. A similar transition occurred with dendrimers 3C/
D3C and 3B/D3B with an oligoleucine core between pH 7
and pH 6 (orange curves). By contrast, negative control
dendrimers 6C/6B (green curves) were not aggregated and
7C/7B (cyan curves) were aggregated across the entire pH
range. While the fluorescence intensity of the coumarin label
changed by less than 50% across the pH range, the BODIPY
label was entirely quenched above pH 6 in all cases except for
the nonaggregated dendrimer 6B (green curve), reflecting
autoquenching caused by aggregation.62−65
The coumarin label in transfecting dendrimers 1C, D1C,
3C, and D3C underwent a small blue shift between the
nonaggregated state at pH 5.0 and the aggregated state at pH
7.4 (λmax = 480 → 474 nm, Figure 2c). By comparison, the
fluorescence of the nontransfecting nonaggregating dendrimer
Figure 2. pH dependent aggregation of peptide dendrimers: (a) coumarin or (b) BODIPY peptide dendrimer (100 μg/mL) in PB at pH 5.0−7.4
added on dried Nile red (final concentration of 0.2 μM). Fluorescence measured at λex/λem = 540/615 nm for Nile red and of the fluorophore
attached to the dendrimer after the similar serial dilution at λex/λem = 390/470 nm for coumarin and at λex/λem = 493/520 nm for BODIPY.
Fluorescence scans of (c) coumarin or (d) BODIPY labeled peptide dendrimers (100 μg/mL) in PB at pH 5.0−7.4 with excitation wavelengths at
λex = 390 nm for coumarin and at λex = 493 nm for BODIPY. RFU = Relative fluorescence unit.
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6C was constant and close to the lower value (λmax = 482 nm),
and that of the nontransfecting aggregated dendrimer 7C was
constant at the higher value (λmax = 474 nm). The difference in
fluorescence of the BODIPY label in 1B, D1B, 3B, and D3B
between pH 5.0 and pH 7.4 corresponded to a small red shift
(λmax = 522 → 535 nm, Figure 2d). In this case, the
fluorescence of the nonaggregated nontransfecting dendrimer
6B was constant at the lower value (λmax = 522 nm), while that
of the nontransfecting aggregated dendrimer 7B behaved
similarly to the transfecting dendrimers (λmax = 522 → 535
nm), in line with the fact that significant unquenching had
already started around pH 5.5.
The observed blue and red shifts in coumarin and BODIPY
fluorescence upon aggregation indicate the formation of
fluorophores H- and J-aggregates66−70 and therefore close
intermolecular interactions between peptide dendrimers in the
aggregated state, which might be mediated by intermolecular
β-sheets (see below) or by close contact between two
dendrimers as recently documented in an X-ray crystal
structure of a related peptide dendrimer.71
Circular dichroism (CD) spectra recorded at pH 7.4 or at
pH 5.0 with or without 5 mM dodecyl phosphocholine (DPC)
as a membrane-like environment72,73 showed that the
secondary structure content of our dendrimers changed with
pH and aggregation state (Figure 3a−f). The CD traces of
lipidated dendrimers 1C/D1C (Figure 3a) and 1B/D1B
(Figure 3d) under the different conditions showed an
isosbestic point indicating a transition between two states
consisting of a β-sheet conformation in their aggregated state
at pH 7.4 (yellow lines, broad max/min at λ ∼ 195−200 nm
and single broad min/max at λ ∼ 220 nm for L/D-peptides),
which was slightly enhanced in the presence of DPC (cyan
lines), to a partially α-helical conformation at pH 5.0 in the
presence of DPC (green lines, sharp max/min at λ ∼ 190−195
nm double min/max at λ ∼ 208 and 222 nm for L/D-peptides)
via a random coil at pH 5.0 without DPC (red lines, broad
min/max at λ ∼ 200 nm for L/D-peptides). Dendrimers 3C/
D3C (Figure 3b) and 3B/D3B (Figure 3e) similarly
transitioned from a predominantly β-sheet conformation at
pH 7.4 with or without DPC (yellow and cyan lines) to a
random coil at pH 5.0 (red lines) and finally an α-helical
conformation with DPC, although there was no clear isosbestic
point.
Figure 3. pH dependent secondary structure and siRNA binding of peptide dendrimers. (a−f) Conformation of transfection peptide dendrimers in
solution at pH 5.0 and pH 7.4 and in the presence of DPC micelles. Circular dichroism spectra of coumarin (a−c) and BODIPY (d−f) peptide
dendrimers (100 μg/mL) in 10 mM phosphate buffer (PB) at pH 5.0 or pH 7.4 in absence or presence of dodecylphosphocholine (DPC, 5 mM).
(g) Free siRNA assay by intercalation of Quant-it microRNA in complexes of siRNA (20 nM) and peptide dendrimers (N/P 1−10, 42−420 nM,
0.3−3 μg/mL) as a function of the N/P ratio at pH 7.4 in Quant-it microRNA buffer. Readings at N/P = 10 were the same as at N/P = 5 (data not
shown). (h) is the same as (g) at pH 5.0 in Quant-it microRNA buffer acidified with 10 mM acetate buffer. Fluorescence normalized to siRNA
alone was set as 100%. All experiments were performed in triplicate. (i) Acid-based titration of D3C.
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The CD spectra of the nonaggregating and nontransfecting
dendrimers 6C (full lines, Figure 3c) and 6B (full lines, Figure
3f) again showed an isosbestic point, with an α-helical
conformation at pH 7.4 with (cyan lines) or without (yellow
lines) DPC, as well as at pH 5.0 with DPC (green lines), and a
random coil at pH 5.0 (red lines). Finally, the CD spectra of
the nontransfecting dendrimers 7C (dashed lines, Figure 3c)
and 7B (dashed lines, Figure 2f), which are aggregated at all
pH values and bind siRNA tightly, showed a very similar β-
sheet containing conformation under all conditions. Overall,
the CD spectra indicated a transition from a β-sheet
conformation in the aggregated state to a random coil or α-
helical conformation in the nonaggregated state across all
transfecting dendrimers.
We next measured siRNA binding for the coumarin-labeled
series as a function of pH and N/P ratio using the Quant-it
microRNA assay. All dendrimers completely bound siRNA
above N/P = 5 at pH 7.4 (Figure 3g) and above N/P = 2 at
pH 5.0 (Figure 3h). The tightest binding was observed with
inactive dendrimer 7C and the weakest binding with inactive
dendrimer 6C. As demonstrated previously with nonlabeled
dendrimers and verified here with D3C, amino termini
underwent protonation at approximately pH 6, leading to
eight additional positive charges per dendrimer upon acid-
ification. This protonation explains the different stoichiome-
tries of siRNA binding between pH 7.4 and pH 5.0 (Figure 3i).
Furthermore, the correlation between β-sheet content and
aggregation noted above suggests that aggregation is mediated
by intermolecular β-sheet cross-links and is necessary for
siRNA binding.
We further characterized the pH dependent aggregation of
our dendrimers as siRNA complexes at pH 7.4 or pH 5.0 using
dynamic light scattering for the case of the BODIPY
dendrimers, because they showed the most interesting
fluorescence modulation (DLS, N/P = 10, Figure 4).74 The
size distribution of siRNA complexes decreased from 80 to 150
nm at pH 7.4 to 60−100 nm at pH 5.0, while the zeta potential
value distribution increased from 10 to 20 mV at pH 7.4 to
20−50 mV at pH 5.0, reproducing our previous observations
with DMH13 and DMH18. We interpret these changes as
partial release of the dendrimer caused by protonation of the
multiple N-termini leading to an increased number of positive
charges on the dendrimer, forming more compact but also
more stable nanoparticles at lower pH.
Figure 4. (a) Dynamic light scattering and (b) zeta potential of siRNA (1.6 μM) and peptide dendrimers (N/P 10, 30.5−42 μM, 232−287 μg/
mL) alone or in complexes formed in PB at pH 5.0 and 7.4. All data shown have a polydispersity index (PDI) < 0.5. Curves are missing when no
particles were detected.
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The DLS data of the dendrimers alone showed that,
depending on the particular dendrimer, their aggregates at pH
7.4 were either smaller (DMH13, 6B), similarly sized (D1B,
3B, D3B), or larger (1B, DMH18, 7B) than their siRNA
complexes and had comparable zeta potential value distribu-
tions. At pH 5.0, the free dendrimers all formed smaller
nanoparticles than at pH 7.4, or no aggregates at all (DMH18,
6B), in line with the Nile Red assay discussed above. In all
cases, the zeta potential value distributions were similar to the
siRNA complexes indicating more stable nanoparticles at lower
pH.
Taken together, these experiments were consistent with our
previous studies with DMH13, DMH18, and other nonlabeled
analogs and showed that our fluorescence labeled dendrimers
behaved similarly to their nonlabeled parents in terms of pH
dependent aggregation, secondary structure, and siRNA
binding properties, with comparable variations as a function
of changes in hydrophobicity, positive charges, and chirality.
Figure 5. pH dependent complex dissociation and monomer release. Fluorescence scans of complex formed with Cy3-siRNA (100 nM) and (a)
Cmr and (b) Bdp peptide dendrimers (N/P 2 or 10, μM, 3 or 15 μg/mL) or peptide dendrimers alone (15 μg/mL) at pH 5.0−7.4 with excitation
wavelengths at λex = 390 nm for Cmr and at λex = 493 nm for Bdp. (c) FRET efficiency in complexes formed as above at pH 5.0−7.4 taken from
scans at wavelength of λdonor/λacceptor = 470/574 nm for Cmr and λdonor/λacceptor = 520/574 nm for Bdp. Ratio of fluorescence intensity at the same
wavelength for peptide dendrimers alone was added for comparison purposes. Fluorescence scans at pH 5.0−7.4 in these conditions are present in
Figure S5. RFU = Relative fluorescence unit.
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FRET Studies. We next performed fluorescence resonance
energy transfer (FRET) studies with Cy3-labeled siRNA to
directly probe the proximity of siRNA−dendrimer interactions.
The fluorescence of the Cy3-label occurred at λem = 574 nm
upon excitation at λex = 530 nm but was negligible when using
the excitation wavelength of the coumarin (λex = 390 nm) or
BODIPY (λex = 493 nm) label. These properties made it
possible to monitor FRET and therefore a direct interaction
between siRNA and dendrimer by recording Cy3 fluorescence
at λem = 574 nm by exciting at the excitation wavelength of the
dendrimer labels.
The fluorescence of the coumarin-labeled transfection
dendrimers 1C/D1C and 3C/D3C at pH 7.4 (λex = 390
nm, λem = 470 nm) was very strongly reduced upon
complexation with Cy3-siRNA at N/P = 2 or N/P = 10,
producing at the same time a FRET emission of Cy3-siRNA at
λem = 574 nm, indicating a close association between
dendrimer and siRNA (Figure 5a, cyan curves). At pH 5.0
by contrast, siRNA complexation did not significantly reduce
the intensity of dendrimer fluorescence for 1C/D1C and 3C/
D3C (λem = 470 nm), while the FRET effect to Cy3-siRNA
was eliminated with N/P = 10 but preserved at N/P = 2,
indicating that most but not all of the dendrimer was
dissociated from siRNA at pH 5.0 (Figure 5a, red curves).
For the nontransfecting dendrimer 6C, Cy3-siRNA complex-
ation did not induce any significant change in dendrimer
fluorescence or FRET at both pH values, in line with its weak
siRNA binding ability. For the nontransfecting dendrimer 7C,
by contrast, Cy3-siRNA complexation caused a strong
reduction in dendrimer fluorescence and significant FRET at
both pH 7.4 and pH 5.0, reflecting its tight siRNA binding
across the entire pH range studied.
For the BODIPY labeled transfection dendrimers 1B/D1B
and 3B/D3B, a strong autoquenching occurred for all
dendrimers at pH 7.4 with or without bound siRNA, together
with a FRET emission by bound Cy3-siRNA which was
particularly strong at N/P = 2, reflecting a close proximity
between these dendrimers and Cy3-siRNA (Figure 5b, cyan
curves). Autoquenching was strongly reduced for these
dendrimers at pH 5.0 indicating disaggregation. However, as
for the coumarin labeled dendrimers discussed above, FRET to
Cy3-siRNA remained strong at N/P = 2, showing that some
dendrimer remained bound to siRNA (Figure 5b, red curves).
The nontransfecting dendrimer 6B behaved similarly except
for reduced autoquenching at pH 7.4 and N/P = 10 and a
somewhat weaker FRET at N/P = 2 at both pH values,
reflecting its lower siRNA binding and aggregating ability.
Finally, the nontransfecting dendrimer 7B showed strong
autoquenching and FRET at both pH values, as expected from
its tight siRNA binding ability.
We further determined the pH dependence of the FRET
efficiency between dendrimer and siRNA for the coumarin
Figure 6. Evidence for membrane disruption at various pH values by transfection peptide dendrimers. (a) Sulforhodamine B leakage from
phosphatidyl choline lipid vesicles suspended in buffer (125 μM EYPC, 625 μM SRB, 10 mM PB; pH 5.0, 6.0, and 7.4). After 30 s, peptide
dendrimers (7.5 μg/mL) or complexes formed with siRNA (50 nM) and peptide dendrimers (N/P 10, 1.05 μM, 7.5 μg/mL) were added to the
lipid vesicle solution. After 270 s, Triton X-100 (0.625%) was added for full release of SRB and measured at λex = 565 nm and at λex = 586 nm.
Leakage properties of L2000 are present in Figure S6. (b) SRB leakage from EYPC vesicle with Cmr labeled peptide dendrimers (1.05 μM, 7.5 μg/
mL) after 30 min incubation at pH 5.0−7.4. (c) is the same as (b) with Bdp labeled peptide dendrimers. It = ratio of fluorescence intensity.
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(λdonor/λacceptor = 470/574 nm) and BODIPY (λdonor/λacceptor =
520/574 nm) between pH 7.4 and pH 5.0 (Figure 5c). This
data illustrated the gradual decrease in close dendrimer siRNA
interactions upon acidification for the eight transfection
dendrimers (1C/1B, D1C/D1B, 3C/3B, D3C/D3B). The
generally low level of association for the weakly binding,
nontransfecting dendrimers 6C/6B and the almost pH-
independent tight association of siRNA with the tight binding,
nontransfecting dendrimers 7C/7B were also evident in this
pH profile.
The above FRET experiments were overall consistent with
the aggregation studies discussed above and showed that
dendrimers and siRNA interact in close proximity within the
formed nanoparticles at pH 7.4, which upon acidification to
pH 5.0 release most of the dendrimer into solution while
leaving some dendrimer closely complexed with siRNA.
Membrane Disruption. In our mechanistic model, the
free dendrimer liberated from the dendrimer/siRNA nano-
particle upon acidification of the endosome facilitates endo-
some escape by destabilizing the endosomal membrane. We
had previously shown by vesicle leakage assays that our
transfection dendrimers can disrupt lipid vesicles consisting of
zwitterionic egg yolk phosphatidyl choline (EYPC) loaded
with fluorescein as reporter dye; however, these experiments
were carried out at pH 7.4. To test their membrane disrupting
activity under the acidic conditions of the endosome, we
carried out these experiments at pH 7.4, pH 6.0, and pH 5.0
using either the free dendrimers or their siRNA complexes at
Figure 7. Cellular uptake and localization of Cy3-siRNA and Cmr-labeled peptide dendrimer. (a) Geo mean fluorescence intensity (GMFI) of
internalized Cy3-siRNA (100 nM) and Cmr peptide dendrimers (N/P 10, 2.1 μM, 15 μg/mL) in HeLa cells after 4 h transfection. The gray line
represents the colocalization of both dyes determined by the software (the higher the value the more colocalized). Error bars represent the standard
deviation of two independent experiments, and all results are normalized to cell mask deep red (CMDR, Figure S9). (b) Internalization of the
peptide dendrimers alone (2.1 μM, 15 μg/mL) in HeLa cells after 4 h incubation. (c) Live cells confocal microscopy of Cy3-siRNA (green) and
peptide dendrimers (blue) in HeLa cells. HeLa cells were incubated with Cy3-siRNA (100 nM) and peptide dendrimers (N/P 10, 2.1 μM, 15 μg/
mL) for 4 h in Opti-MEM. The plasma membrane was stained with Cell mask deep red. White scale bars represent 50 μm (lens ×40/1.3). Non-
overlaid images are shown in Figure S8.
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N/P = 10. We loaded the vesicles with sulforhodamine B
(SRB),75 a pH-independent reporter dye whose fluorescence
wavelengths (λex = 565 nm, λem = 586 nm) did not interfere
with the fluorescent labels of our dendrimers.
All dendrimers had a strong membrane disruptive activity at
pH 7.4 (Figure 6a, cyan lines). This activity was significantly
reduced upon siRNA complexation in all cases except 3C and
D3C and was entirely suppressed for tight binding non-
transfecting dendrimers 7C and 7B (Figure 6a, dashed cyan
lines). At pH 6.0, the membrane disruptive activity was almost
as strong for both free dendrimer and siRNA complexes in all
cases except for the nontransfecting dendrimers 6C/6B and
the siRNA complexed nontransfecting dendrimer 7C (Figure
6a, orange lines). All transfection dendrimers retained their
membrane disruptive activity upon further acidification to pH
5.0, although the nontransfecting dendrimers 6C and 6B
became almost completely inactive (Figure 6a, red lines).
However, extending the vesicle incubation time to 30 min,
which would be somewhat closer to the residence times of
dendrimers during transfection, led to extensive vesicle leakage
for all dendrimers across the entire pH range in both the
coumarin labeled series (Figure 6b) and the BODIPY labeled
series (Figure 6c).
Taken together, these data indicated that the 8-fold
protonation of dendrimer amino-termini and the accompany-
ing change in secondary structure and aggregation state taking
place upon acidification reduced but did not abolish the
membrane disruptive activity of our dendrimers. Although
EYPC vesicles are very simplified compared to endosomes,
these experiments suggest that the dendrimers probably
participate in endosomal membrane disruption as part of the
overall transfection mechanism.
Fluorescence Imaging of Cellular Uptake of Den-
drimer/siRNA Complexes. We previously showed that the
nanoparticles formed upon siRNA complexation by our
transfection dendrimers enter cells by endocytosis and
eventually escape the endosome to release their cargo into
the cytosol. Here, the availability of fluorescently labeled
dendrimers allowed us to investigate if siRNA and dendrimers
were colocalized during the transfection process. To investigate
this point, we used the coumarin labeled series together with a
fluorescence labeled Cy3-siRNA56 to track both reagents
separately upon internalization of the dendrimer/siRNA
complexes into HeLa cells.
Flow cytometry showed comparable uptake values for
dendrimer and for siRNA across the different dendrimers, as
expected from the fact that these reagents are internalized into
cells as complexes (Figure 7a). The internalization levels were
slightly higher for D1C and D3C compared to their L-
enantiomers 1C and 3C, in line with the stronger transfection
efficiency of the D-enantiomers. The highest level of internal-
ization occurred with the nontransfecting dendrimer 7C, which
internalizes but does not release its siRNA cargo into the cells.
On the other hand, dendrimer 6C, which only binds siRNA
weakly, showed significantly lower internalization levels of
Cy3-siRNA than of dendrimer, suggesting that some
uncomplexed dendrimer also internalizes into cells in this case.
The dendrimers also internalized into cells without siRNA
complexation, with relative levels corresponding to those of
their siRNA complexes. This showed that internalization
efficiency was primarily dictated by the dendrimer, which is not
surprising if one considers that the dendrimer/siRNA
complexes formed at N/P = 10 contain an excess of dendrimer
(Figure 7b). However, there were no significant differences
between L- and D-enantiomers in the case of 1C/D1C and 3C/
D3C. The absence of enantioselectivity in cellular uptake of
the dendrimers without siRNA suggests that the process is not
receptor mediated. We therefore believe that the small
differences observed between 1C/3C and their enantiomers
D1C/D3C in cellular uptake of their siRNA complexes (Figure
7a) and their knock-down efficiency (Table 1) reflect a small
level of diastereoselectivity in dendrimer−siRNA interactions
influencing nanoparticle properties and siRNA release. We
obtained similar results with CHO and HEK-293 cells (Figure
S7).
Confocal images of transfected cells confirmed the flow
cytometry data in terms of the amounts of cellular uptake
(Figure 7c, Figure S8). Dendrimers and siRNA were mostly
colocalized in punctuate patterns attributable to endosomes
and lysosomes, with only very limited spread of fluorescence in
the cytosol, in line with our previous observation with
fluorescent siRNA and unlabeled dendrimers, an effect which
has also been reported with other transfection reagents.76−80
Thus, although we did not observe any significant separation of
dendrimer and siRNA fluorescence in these images, the level of
fluorescence in the cytosol was generally too low to detect a
possible separation of dendrimers from siRNA after endosome
escape. We made similar observation in CHO and HEK-293
cells (Figures S9 and S10).
■ CONCLUSION
Here, we identified coumarin-labeled siRNA transfection
dendrimers D1C/D3C and BODIPY-labeled dendrimers
D1B/D3B as analogs of the previously reported transfection
dendrimers DMH13/DMH18. Detailed investigations includ-
ing nontransfecting dendrimers 6C/6B (weak siRNA binding)
and 7C/7B (excessive siRNA binding) showed that these
fluorescently labeled dendrimers behave similarly to their
nonlabeled parents in terms of pH dependent aggregation,
secondary structure content, and siRNA binding.
We then exploited dendrimer fluorescence to perform FRET
studies, which showed that the dendrimers are in close
proximity to siRNA within the nanoparticles formed at pH 7.4
but are then mostly released into solution upon acidification to
pH 5.0, modeling the conditions within the endosome. Vesicle
leakage assays showed that the liberated dendrimer can disrupt
model membranes at pH 5.0 almost as well as at pH 7.4,
suggesting that the dendrimers participate in endosome escape
by permeabilizing the endosomal membrane. Finally, we
tracked siRNA transfection by confocal microscopy, which
showed that the dendrimers colocalize with siRNA within the
cells throughout the transfection process. Additional mecha-
nistic studies regarding the internalization mechanism of our
fluorescent transfection dendrimers might be possible as
recently reported for siRNA delivery nanoparticles derived
from cell penetrating peptides.81
While the present studies with fluorescently labeled peptide
dendrimers provided novel insights into the mechanism of
siRNA complexation and transfection, they also highlight that
siRNA transfection by our peptide dendrimers is compatible
with a variety of hydrophobic cores as long as the dendrimer
branches are kept constant, suggesting a simple design strategy
for nanoparticle forming peptide dendrimers, and a broad
optimization potential for transfection applications. Never-
theless, the best system in terms of transfection efficiency
across all fluorescent and nonfluorescent peptide dendrimers
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studied thus far is the amino-acid-only dendrimer DMH18 due
to its ease of synthesis, low toxicity, and high transfection
efficiency across different cell lines.
■ METHODS
Synthesis and characterization of peptide dendrimers, all assays
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